$324M
$333,000
0.0% of portfolio
73,975
Q2 2025
New
$910M
$368,000
0.0% of portfolio
16,829
Q2 2025
New
$79.7B
$436,000
0.0% of portfolio
1,037
Q2 2025
Reduced 36.85%
$51.3B
$236,000
0.0% of portfolio
4,583
Q4 2024
New
$584M
$780,000
0.0% of portfolio
53,891
Q2 2025
Added 438.26%
$589M
$405,000
0.0% of portfolio
76,272
Q2 2025
Added 327.87%
$1.48B
$302,000
0.0% of portfolio
37,358
Q2 2025
Added 268.17%
$52.1B
$674,000
0.0% of portfolio
9,061
Q2 2025
Added 13.02%
$401M
$278,000
0.0% of portfolio
16,561
Q2 2025
New
$1.86B
$332,000
0.0% of portfolio
14,437
Q2 2025
Reduced 41.82%
-
$0
0.0% of portfolio
-
Q2 2025
Added 21.5%
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.02B
$184,000
0.0% of portfolio
25,233
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 158.1%
-
$0
0.0% of portfolio
-
Q2 2025
New
$465M
$532,000
0.0% of portfolio
48,566
Q2 2025
Reduced 70.57%
$105B
$298,000
0.0% of portfolio
2,216
Q2 2025
New
$834M
$492,000
0.0% of portfolio
16,937
Q2 2025
Reduced 36.28%
$920M
$191,000
0.0% of portfolio
11,334
Q2 2025
New
$0
$173,000
0.0% of portfolio
11,880
Q2 2025
Reduced 98.27%
Neumora Therapeutics Inc.
-
$0
0.0% of portfolio
-
Q2 2025
Added 149.66%
$3.03B
$208,000
0.0% of portfolio
17,190
Q2 2025
New
$8.21B
$273,000
0.0% of portfolio
396
Q2 2025
New
$6.28B
$772,000
0.0% of portfolio
22,525
Q2 2025
Added 236.55%
$292M
$284,000
0.0% of portfolio
25,260
Q2 2025
New
$160M
$17,000
0.0% of portfolio
37,342
Q2 2023
New
$329M
$367,000
0.0% of portfolio
221,563
Q2 2025
Added 119.86%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 45.01%
$420M
$305,000
0.0% of portfolio
49,795
Q2 2025
Added 194.04%
$95.9M
$135,000
0.0% of portfolio
81,917
Q2 2025
Added 28.47%
$1.34B
$366,000
0.0% of portfolio
18,629
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 637.39%
$26.3B
$119,000
0.0% of portfolio
23,115
Q2 2025
Added 62.59%
$22.5B
$167,000
0.0% of portfolio
25,448
Q2 2025
Added 20.71%
$831M
$445,000
0.0% of portfolio
111,870
Q2 2025
Added 312.96%
$27B
$550,000
0.0% of portfolio
4,340
Q2 2025
Reduced 84.87%
$569M
$194,000
0.0% of portfolio
16,921
Q2 2025
Reduced 3.78%
$1.46B
$480,000
0.0% of portfolio
12,093
Q2 2025
Added 79.24%
$3.27B
$673,000
0.0% of portfolio
13,123
Q2 2025
Reduced 15.56%
$2.43B
$75,000
0.0% of portfolio
18,345
Q2 2025
Added 50.95%
$596M
$292,000
0.0% of portfolio
36,589
Q2 2025
Reduced 4.87%
$30.4B
$298,000
0.0% of portfolio
5,129
Q2 2025
New
$684M
$228,000
0.0% of portfolio
117,182
Q2 2025
Added 327.44%
$0
$172,000
0.0% of portfolio
14,462
Q1 2025
Added 0.01%
$0
$147,000
0.0% of portfolio
13,215
Q2 2025
Reduced 7.93%
$0
$92,000
0.0% of portfolio
10,604
Q2 2025
New
$0
$87,000
0.0% of portfolio
10,378
Q4 2024
Reduced 0.97%
$0
$111,000
0.0% of portfolio
13,843
Q2 2025
Reduced 6.66%
$58.3B
$585,000
0.0% of portfolio
2,680
Q2 2025
Reduced 59.95%
$2.42B
$746,000
0.0% of portfolio
36,027
Q2 2025
Added 101.92%